zip file name: P00.zip 122 CEL files eaId specimenId tumorName tumorType histology sampleType passage replicate xenograftMouseStrain arraySource arrayType comments fileName EA06017_129769 154 786-0 renal adenocarcinoma Cells P00 T1 10% Serum Affymetrix HG U133 Plus 2 null EA06017_129769_H133+_154.CEL EA06017_129770 155 786-0 renal adenocarcinoma Cells P00 T2 10% Serum Affymetrix HG U133 Plus 2 null EA06017_129770_H133+_155.CEL EA06017_129771 156 786-0 renal adenocarcinoma Cells P00 T3 10% Serum Affymetrix HG U133 Plus 2 null EA06017_129771_H133+_156.CEL EA06017_107310 27 A375 melanoma metastatic malignant melanoma Cells P00 T1 10% Serum Affymetrix HG U133 Plus 2 null EA06017_107310_H133+_27.CEL EA06017_107311 28 A375 melanoma metastatic malignant melanoma Cells P00 T2 10% Serum Affymetrix HG U133 Plus 2 null EA06017_107311_H133+_28.CEL EA06017_129784 172 A549 lung adenocarcinoma Cells P00 T1 10% Serum Affymetrix HG U133 Plus 2 null EA06017_129784_H133+_172.CEL EA06017_129785 173 A549 lung adenocarcinoma Cells P00 T2 10% Serum Affymetrix HG U133 Plus 2 null EA06017_129785_H133+_173.CEL EA06017_129786 174 A549 lung adenocarcinoma Cells P00 T3 10% Serum Affymetrix HG U133 Plus 2 null EA06017_129786_H133+_174.CEL EA06017_107292 9 A549/Asc-1 lung adenocarcinoma Cells P00 T1 10% Serum Affymetrix HG U133 Plus 2 null EA06017_107292_H133+_9.CEL EA06017_107293 10 A549/Asc-1 lung adenocarcinoma Cells P00 T2 10% Serum Affymetrix HG U133 Plus 2 null EA06017_107293_H133+_10.CEL EA06017_107364 81 AS283 lymphoma AIDs related Burkitts lymphoma Cells P00 T1 10% Serum Affymetrix HG U133 Plus 2 null EA06017_107364_H133+_81.CEL EA06017_107365 82 AS283 lymphoma AIDs related Burkitts lymphoma Cells P00 T2 10% Serum Affymetrix HG U133 Plus 2 null EA06017_107365_H133+_82.CEL EA06017_107356 73 AsPC-1 pancreatic adenocarcinoma Cells P00 T1 10% Serum Affymetrix HG U133 Plus 2 null EA06017_107356_H133+_73.CEL EA06017_107357 74 AsPC-1 pancreatic adenocarcinoma Cells P00 T2 10% Serum Affymetrix HG U133 Plus 2 null EA06017_107357_H133+_74.CEL EA06017_116523 115 AsPC-1 pancreatic adenocarcinoma Cells P00 T3 10% Serum Affymetrix HG U133 Plus 2 null EA06017_116523_H133+_115.CEL EA06017_107368 85 CA46 lymphoma lymphoblastic Burkitt's lymphoma Cells P00 T1 10% Serum Affymetrix HG U133 Plus 2 null EA06017_107368_H133+_85.CEL EA06017_107369 86 CA46 lymphoma lymphoblastic Burkitt's lymphoma Cells P00 T2 10% Serum Affymetrix HG U133 Plus 2 null EA06017_107369_H133+_86.CEL EA06017_107328 45 CAKI-1 renal renal Cell carcinoma Cells P00 T1 10% Serum Affymetrix HG U133 Plus 2 null EA06017_107328_H133+_45.CEL EA06017_107329 46 CAKI-1 renal renal Cell carcinoma Cells P00 T2 10% Serum Affymetrix HG U133 Plus 2 null EA06017_107329_H133+_46.CEL EA06017_129733 118 CCRF-CEM leukemia acute lymphoblastic (T-ALL) Cells P00 T1 10% Serum Affymetrix HG U133 Plus 2 null EA06017_129733_H133+_118.CEL EA06017_129734 119 CCRF-CEM leukemia acute lymphoblastic (T-ALL) Cells P00 T2 10% Serum Affymetrix HG U133 Plus 2 null EA06017_129734_H133+_119.CEL EA06017_129735 120 CCRF-CEM leukemia acute lymphoblastic (T-ALL) Cells P00 T3 10% Serum Affymetrix HG U133 Plus 2 null EA06017_129735_H133+_120.CEL EA06017_90487 6 COLO 205 colon adenocarcinoma Cells P00 T1 10% Serum Affymetrix HG U133 Plus 2 null EA06017_90487_H133+_6.CEL EA06017_90488 7 COLO 205 colon adenocarcinoma Cells P00 T2 10% Serum Affymetrix HG U133 Plus 2 null EA06017_90488_H133+_7.CEL EA06017_90489 8 COLO 205 colon adenocarcinoma Cells P00 T3 10% Serum Affymetrix HG U133 Plus 2 null EA06017_90489_H133+_8.CEL EA06017_107312 29 COLO 829 melanoma malignant melanoma Cells P00 T1 10% Serum Affymetrix HG U133 Plus 2 null EA06017_107312_H133+_29.CEL EA06017_107313 30 COLO 829 melanoma malignant melanoma Cells P00 T2 10% Serum Affymetrix HG U133 Plus 2 null EA06017_107313_H133+_30.CEL EA06017_107346 63 CP70 ovarian carcinoma Cells P00 T1 10% Serum Affymetrix HG U133 Plus 2 null EA06017_107346_H133+_63.CEL EA06017_107347 64 CP70 ovarian carcinoma Cells P00 T2 10% Serum Affymetrix HG U133 Plus 2 null EA06017_107347_H133+_64.CEL EA06017_107298 15 EKVX lung adenocarcinoma Cells P00 T1 10% Serum Affymetrix HG U133 Plus 2 null EA06017_107298_H133+_15.CEL EA06017_107299 16 EKVX lung adenocarcinoma Cells P00 T2 10% Serum Affymetrix HG U133 Plus 2 null EA06017_107299_H133+_16.CEL EA06017_107352 69 GTL-16 gastric adenocarcinoma Cells P00 T1 10% Serum Affymetrix HG U133 Plus 2 null EA06017_107352_H133+_69.CEL EA06017_107353 70 GTL-16 gastric adenocarcinoma Cells P00 T2 10% Serum Affymetrix HG U133 Plus 2 null EA06017_107353_H133+_70.CEL EA06017_90490 14 HCC-2998 colon carcinoma Cells P00 T1 10% Serum Affymetrix HG U133 Plus 2 null EA06017_90490_H133+_14.CEL EA06017_90491 15 HCC-2998 colon carcinoma Cells P00 T2 10% Serum Affymetrix HG U133 Plus 2 null EA06017_90491_H133+_15.CEL EA06017_90492 16 HCC-2998 colon carcinoma Cells P00 T3 10% Serum Affymetrix HG U133 Plus 2 null EA06017_90492_H133+_16.CEL EA06017_90493 22 HCT-116 colon carcinoma Cells P00 T1 10% Serum Affymetrix HG U133 Plus 2 null EA06017_90493_H133+_22.CEL EA06017_90494 23 HCT-116 colon carcinoma Cells P00 T2 10% Serum Affymetrix HG U133 Plus 2 null EA06017_90494_H133+_23.CEL EA06017_90495 24 HCT-116 colon carcinoma Cells P00 T3 10% Serum Affymetrix HG U133 Plus 2 null EA06017_90495_H133+_24.CEL EA06017_90496 30 HCT-15 colon adenocarcinoma Cells P00 T1 10% Serum Affymetrix HG U133 Plus 2 null EA06017_90496_H133+_30.CEL EA06017_90497 31 HCT-15 colon adenocarcinoma Cells P00 T2 10% Serum Affymetrix HG U133 Plus 2 null EA06017_90497_H133+_31.CEL EA06017_90498 32 HCT-15 colon adenocarcinoma Cells P00 T3 10% Serum Affymetrix HG U133 Plus 2 null EA06017_90498_H133+_32.CEL EA06017_107362 79 HeLa-Luc cervical adenocarcinoma Cells P00 T1 10% Serum Affymetrix HG U133 Plus 2 null EA06017_107362_H133+_79.CEL EA06017_107363 80 HeLa-Luc cervical adenocarcinoma Cells P00 T2 10% Serum Affymetrix HG U133 Plus 2 null EA06017_107363_H133+_80.CEL EA06017_107290 7 HL-60(TB) leukemia promyelocytic Cells P00 T1 10% Serum Affymetrix HG U133 Plus 2 null EA06017_107290_H133+_7.CEL EA06017_107291 8 HL-60(TB) leukemia promyelocytic Cells P00 T2 10% Serum Affymetrix HG U133 Plus 2 null EA06017_107291_H133+_8.CEL EA06017_129736 121.1 HL-60(TB) leukemia promyelocytic Cells P00 T3 10% Serum Affymetrix HG U133 Plus 2 null EA06017_129736_H133+_121.1.CEL EA06017_129737 122 HL-60(TB) leukemia promyelocytic Cells P00 T4 10% Serum Affymetrix HG U133 Plus 2 null EA06017_129737_H133+_122.CEL EA06017_129738 123 HL-60(TB) leukemia promyelocytic Cells P00 T5 10% Serum Affymetrix HG U133 Plus 2 null EA06017_129738_H133+_123.CEL EA06017_129781 166 HOP-62 lung adenocarcinoma Cells P00 T1 10% Serum Affymetrix HG U133 Plus 2 null EA06017_129781_H133+_166.CEL EA06017_129782 167 HOP-62 lung adenocarcinoma Cells P00 T2 10% Serum Affymetrix HG U133 Plus 2 null EA06017_129782_H133+_167.CEL EA06017_129783 168 HOP-62 lung adenocarcinoma Cells P00 T3 10% Serum Affymetrix HG U133 Plus 2 null EA06017_129783_H133+_168.CEL EA06017_129775 160 HOP-92 lung large cell, undifferentiated Cells P00 T1 10% Serum Affymetrix HG U133 Plus 2 null EA06017_129775_H133+_160.CEL EA06017_129776 161 HOP-92 lung large cell, undifferentiated Cells P00 T2 10% Serum Affymetrix HG U133 Plus 2 null EA06017_129776_H133+_161.CEL EA06017_129777 162 HOP-92 lung large cell, undifferentiated Cells P00 T3 10% Serum Affymetrix HG U133 Plus 2 null EA06017_129777_H133+_162.CEL EA06017_90499 38 HT-29 colon adenocarcinoma, GR III Cells P00 T1 10% Serum Affymetrix HG U133 Plus 2 null EA06017_90499_H133+_38.CEL EA06017_90500 39 HT-29 colon adenocarcinoma, GR III Cells P00 T2 10% Serum Affymetrix HG U133 Plus 2 null EA06017_90500_H133+_39.CEL EA06017_90501 40 HT-29 colon adenocarcinoma, GR III Cells P00 T3 10% Serum Affymetrix HG U133 Plus 2 null EA06017_90501_H133+_40.CEL EA06017_107354 71 HuH-7 liver Differentiated Hepatocellular carcinoma Cells P00 T1 10% Serum Affymetrix HG U133 Plus 2 null EA06017_107354_H133+_71.CEL EA06017_107355 72 HuH-7 liver Differentiated Hepatocellular carcinoma Cells P00 T2 10% Serum Affymetrix HG U133 Plus 2 null EA06017_107355_H133+_72.CEL EA06017_129739 124 K-562 leukemia chronic myelogenous (blast crisis) Cells P00 T1 10% Serum Affymetrix HG U133 Plus 2 null EA06017_129739_H133+_124.CEL EA06017_129740 125 K-562 leukemia chronic myelogenous (blast crisis) Cells P00 T2 10% Serum Affymetrix HG U133 Plus 2 null EA06017_129740_H133+_125.CEL EA06017_129741 126 K-562 leukemia chronic myelogenous (blast crisis) Cells P00 T3 10% Serum Affymetrix HG U133 Plus 2 null EA06017_129741_H133+_126.CEL EA06017_90502 46 KM12 colon adenocarcinoma Cells P00 T1 10% Serum Affymetrix HG U133 Plus 2 null EA06017_90502_H133+_46.CEL EA06017_90503 47 KM12 colon adenocarcinoma Cells P00 T2 10% Serum Affymetrix HG U133 Plus 2 null EA06017_90503_H133+_47.CEL EA06017_90504 48 KM12 colon adenocarcinoma Cells P00 T3 10% Serum Affymetrix HG U133 Plus 2 null EA06017_90504_H133+_48.CEL EA06017_107302 19 LOX IMVI melanoma malignant amelanocytic melanoma Cells P00 T1 10% Serum Affymetrix HG U133 Plus 2 null EA06017_107302_H133+_19.CEL EA06017_107303 20 LOX IMVI melanoma malignant amelanocytic melanoma Cells P00 T2 10% Serum Affymetrix HG U133 Plus 2 null EA06017_107303_H133+_20.CEL EA06017_107306 23 M14 melanoma adenocarcinoma Cells P00 T1 10% Serum Affymetrix HG U133 Plus 2 null EA06017_107306_H133+_23.CEL EA06017_107307 24 M14 melanoma adenocarcinoma Cells P00 T2 10% Serum Affymetrix HG U133 Plus 2 null EA06017_107307_H133+_24.CEL EA06017_107304 21 MALME-3M melanoma malignant melanoma Cells P00 T1 10% Serum Affymetrix HG U133 Plus 2 null EA06017_107304_H133+_21.CEL EA06017_107305 22 MALME-3M melanoma malignant melanoma Cells P00 T2 10% Serum Affymetrix HG U133 Plus 2 null EA06017_107305_H133+_22.CEL EA06017_107314 31 MCF7 breast adenocarcinoma Cells P00 T1 10% Serum Affymetrix HG U133 Plus 2 null EA06017_107314_H133+_31.CEL EA06017_107315 32 MCF7 breast adenocarcinoma Cells P00 T2 10% Serum Affymetrix HG U133 Plus 2 null EA06017_107315_H133+_32.CEL EA06017_107318 35 MDA-MB-231T breast adenocarcinoma, from mouse Cells P00 T1 10% Serum Affymetrix HG U133 Plus 2 null EA06017_107318_H133+_35.CEL EA06017_107319 36 MDA-MB-231T breast adenocarcinoma, from mouse Cells P00 T2 10% Serum Affymetrix HG U133 Plus 2 null EA06017_107319_H133+_36.CEL EA06017_107320 37 MDA-MB-435 melanoma adenocarcinoma Cells P00 T1 10% Serum Affymetrix HG U133 Plus 2 null EA06017_107320_H133+_37.CEL EA06017_107321 38 MDA-MB-435 melanoma adenocarcinoma Cells P00 T2 10% Serum Affymetrix HG U133 Plus 2 null EA06017_107321_H133+_38.CEL EA06017_107322 39 MDA-N melanoma adenocarcinoma; HER2/ERBB2 transfectant of MDA-MB-435 Cells P00 T1 10% Serum Affymetrix HG U133 Plus 2 null EA06017_107322_H133+_39.CEL EA06017_107323 40 MDA-N melanoma adenocarcinoma; HER2/ERBB2 transfectant of MDA-MB-435 Cells P00 T2 10% Serum Affymetrix HG U133 Plus 2 null EA06017_107323_H133+_40.CEL EA06017_129742 127 MOLT-4 leukemia acute lymphoblastic Cells P00 T1 10% Serum Affymetrix HG U133 Plus 2 null EA06017_129742_H133+_127.CEL EA06017_129743 128 MOLT-4 leukemia acute lymphoblastic Cells P00 T2 10% Serum Affymetrix HG U133 Plus 2 null EA06017_129743_H133+_128.CEL EA06017_129744 129 MOLT-4 leukemia acute lymphoblastic Cells P00 T3 10% Serum Affymetrix HG U133 Plus 2 null EA06017_129744_H133+_129.CEL EA06017_129787 175 NCI-H226 lung squamous carcinoma Cells P00 T1 10% Serum Affymetrix HG U133 Plus 2 null EA06017_129787_H133+_175.CEL EA06017_129788 176 NCI-H226 lung squamous carcinoma Cells P00 T2 10% Serum Affymetrix HG U133 Plus 2 null EA06017_129788_H133+_176.CEL EA06017_129789 177 NCI-H226 lung squamous carcinoma Cells P00 T3 10% Serum Affymetrix HG U133 Plus 2 null EA06017_129789_H133+_177.CEL EA06017_107294 11 NCI-H23 lung adenocarcinoma, NSCLC Cells P00 T1 10% Serum Affymetrix HG U133 Plus 2 null EA06017_107294_H133+_11.CEL EA06017_107295 12 NCI-H23 lung adenocarcinoma, NSCLC Cells P00 T2 10% Serum Affymetrix HG U133 Plus 2 null EA06017_107295_H133+_12.CEL EA06017_129778 163 NCI-H460 lung large cell carcinoma Cells P00 T1 10% Serum Affymetrix HG U133 Plus 2 null EA06017_129778_H133+_163.CEL EA06017_129779 164 NCI-H460 lung large cell carcinoma Cells P00 T2 10% Serum Affymetrix HG U133 Plus 2 null EA06017_129779_H133+_164.CEL EA06017_129780 165 NCI-H460 lung large cell carcinoma Cells P00 T3 10% Serum Affymetrix HG U133 Plus 2 null EA06017_129780_H133+_165.CEL EA06017_107296 13 NCI-H522 lung adenocarcinoma Cells P00 T1 10% Serum Affymetrix HG U133 Plus 2 null EA06017_107296_H133+_13.CEL EA06017_107297 14 NCI-H522 lung adenocarcinoma Cells P00 T2 10% Serum Affymetrix HG U133 Plus 2 null EA06017_107297_H133+_14.CEL EA06017_107338 55 OVCAR-3 ovarian adenocarcinoma Cells P00 T1 10% Serum Affymetrix HG U133 Plus 2 null EA06017_107338_H133+_55.CEL EA06017_107339 56 OVCAR-3 ovarian adenocarcinoma Cells P00 T2 10% Serum Affymetrix HG U133 Plus 2 null EA06017_107339_H133+_56.CEL EA06017_107342 59 OVCAR-5 ovarian adenocarcinoma Cells P00 T1 10% Serum Affymetrix HG U133 Plus 2 null EA06017_107342_H133+_59.CEL EA06017_107343 60 OVCAR-5 ovarian adenocarcinoma Cells P00 T2 10% Serum Affymetrix HG U133 Plus 2 null EA06017_107343_H133+_60.CEL EA06017_107348 65 PC-3 prostate adenocarcinoma Cells P00 T1 10% Serum Affymetrix HG U133 Plus 2 null EA06017_107348_H133+_65.CEL EA06017_107349 66 PC-3 prostate adenocarcinoma Cells P00 T2 10% Serum Affymetrix HG U133 Plus 2 null EA06017_107349_H133+_66.CEL EA06017_129796 184 PC-3/M prostate PC-3 subline isolated from liver metastasisin mice Cells P00 T1 10% Serum Affymetrix HG U133 Plus 2 null EA06017_129796_H133+_184.CEL EA06017_129797 185 PC-3/M prostate PC-3 subline isolated from liver metastasisin mice Cells P00 T2 10% Serum Affymetrix HG U133 Plus 2 null EA06017_129797_H133+_185.CEL EA06017_129798 186 PC-3/M prostate PC-3 subline isolated from liver metastasisin mice Cells P00 T3 10% Serum Affymetrix HG U133 Plus 2 null EA06017_129798_H133+_186.CEL EA06017_129772 157 RXF 393 renal poorly differentiated hypernephroma Cells P00 T1 10% Serum Affymetrix HG U133 Plus 2 null EA06017_129772_H133+_157.CEL EA06017_129773 158 RXF 393 renal poorly differentiated hypernephroma Cells P00 T2 10% Serum Affymetrix HG U133 Plus 2 null EA06017_129773_H133+_158.CEL EA06017_129774 159 RXF 393 renal poorly differentiated hypernephroma Cells P00 T3 10% Serum Affymetrix HG U133 Plus 2 null EA06017_129774_H133+_159.CEL EA06017_107374 91 SF-268 CNS anaplastic astrocytoma Cells P00 T1 10% Serum Affymetrix HG U133 Plus 2 null EA06017_107374_H133+_91.CEL EA06017_107375 92 SF-268 CNS anaplastic astrocytoma Cells P00 T2 10% Serum Affymetrix HG U133 Plus 2 null EA06017_107375_H133+_92.CEL EA06017_107376 93 SF-539 CNS glioblastoma Cells P00 T1 10% Serum Affymetrix HG U133 Plus 2 null EA06017_107376_H133+_93.CEL EA06017_107377 94 SF-539 CNS glioblastoma Cells P00 T2 10% Serum Affymetrix HG U133 Plus 2 null EA06017_107377_H133+_94.CEL EA06017_107330 47 SN12C renal carcinoma Cells P00 T1 10% Serum Affymetrix HG U133 Plus 2 null EA06017_107330_H133+_47.CEL EA06017_107331 48 SN12C renal carcinoma Cells P00 T2 10% Serum Affymetrix HG U133 Plus 2 null EA06017_107331_H133+_48.CEL EA06017_129748 133 SR leukemia poorly differentiated B cell origin Cells P00 T1 10% Serum Affymetrix HG U133 Plus 2 null EA06017_129748_H133+_133.CEL EA06017_129749 134 SR leukemia poorly differentiated B cell origin Cells P00 T2 10% Serum Affymetrix HG U133 Plus 2 null EA06017_129749_H133+_134.CEL EA06017_129750 135 SR leukemia poorly differentiated B cell origin Cells P00 T3 10% Serum Affymetrix HG U133 Plus 2 null EA06017_129750_H133+_135.CEL EA06017_90505 54 SW-620 colon adenocarcinoma Cells P00 T1 10% Serum Affymetrix HG U133 Plus 2 null EA06017_90505_H133+_54.CEL EA06017_90506 55 SW-620 colon adenocarcinoma Cells P00 T2 10% Serum Affymetrix HG U133 Plus 2 null EA06017_90506_H133+_55.CEL EA06017_90507 56 SW-620 colon adenocarcinoma Cells P00 T3 10% Serum Affymetrix HG U133 Plus 2 null EA06017_90507_H133+_56.CEL EA06017_107336 53 U251 CNS glioblastoma Cells P00 T1 10% Serum Affymetrix HG U133 Plus 2 null EA06017_107336_H133+_53.CEL EA06017_107337 54 U251 CNS glioblastoma Cells P00 T2 10% Serum Affymetrix HG U133 Plus 2 null EA06017_107337_H133+_54.CEL EA06017_107308 25 UACC-62 melanoma malignant melanoma Cells P00 T1 10% Serum Affymetrix HG U133 Plus 2 null EA06017_107308_H133+_25.CEL EA06017_107309 26 UACC-62 melanoma malignant melanoma Cells P00 T2 10% Serum Affymetrix HG U133 Plus 2 null EA06017_107309_H133+_26.CEL EA06017_116525 117 UACC-62 melanoma malignant melanoma Cells P00 T3 10% Serum Affymetrix HG U133 Plus 2 null EA06017_116525_H133+_117.CEL